Skip to main content

Consensi FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 27, 2021.

FDA Approved: Yes (First approved May 31, 2018)
Brand name: Consensi
Generic name: amlodipine and celecoxib
Dosage form: Tablets
Company: Kitov Pharma Ltd.
Treatment for: High Blood Pressure, Osteoarthritis

Consensi (amlodipine and celecoxib) is a calcium channel blocker and nonsteroidal anti-inflammatory drug combination for the treatment of both hypertension and pain associated with osteoarthritis.

Development Timeline for Consensi

May 31, 2018Approval  FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
Oct  2, 2017Kitov Announces Filing by FDA of New Drug Application for KIT-302
Jul 31, 2017Kitov Submits New Drug Application to FDA for KIT-302
Jun 26, 2017Kitov Updates on KIT-302 New Drug Application

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.